• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Alphabet

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidatesIsomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
    Isomorphic Labs
    11 May 2026

    Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates

    Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.

    Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmesIsomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
    Isomorphic Labs
    31 Mar 2025

    Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes

    Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.

Alphabet
    • Life Sciences
  • 1(12 months)
  • abc.xyz
  • Update Information

More venture news

  • Breedr unlocks £20m Series B led by Partech to digitalise the global cattle supply chain
    Breedr
    26 Aug 2026

    Breedr unlocks £20m Series B led by Partech to digitalise the global cattle supply chain

    Series BAgriculture
  • OLIX unlocks £240m Series B led by Fundomo to develop specialised AI inference chips for each stage of token production
    Olix
    3 Aug 2026

    OLIX unlocks £240m Series B led by Fundomo to develop specialised AI inference chips for each stage of token production

    Series BDeep Tech
  • Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
    Mironid
    5 Aug 2026

    Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases

    Series BLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn